Myxoma and antiphospholipid antibodies syndrome. Report of one case;Mixoma y sindrome de anticuerpos antifosfolípidos

Revista Medica de Chile

Volumn 126, Issue 6, 1998, Pages 670-676

  Quintanilla H, Sergio ^a   Ferrer D, Sergio ^a   Bravo M, Mauricio ^a  

^a HOSPITAL MILITAR DE SANTIAGO   (Chile)

Author keywords

Antiphospholipid syndrome; Cerebral palsy; Myxoma

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN ARTERY; CASE REPORT; CEREBROVASCULAR DISEASE; ECHOGRAPHY; FEMALE; HEART TUMOR; HUMAN; IMMUNOLOGY; MYXOMA; RADIOGRAPHY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; FEMALE; HEART NEOPLASMS; HUMANS; MYXOMA;

EID: 3643139791     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. GRINDAL AB, COHEN RJ, SAUL RF ET AL. Cerebral Infartion in young adults. Stroke 1978; 9: 39-42.
2. BOGOUSSLAVSKY J, VAN MELLE G, REGLI F. The Lausanne Stroke Registry: Analysis of 1000 consecutive patients with first stroke. Stroke 1986; 19: 1.083-92.
3. BOGOUSSLAVSKY J, REGLI F. Ischemic Stroke in adults younger than 30 years of age: Cause and Prognosis. Arch Neurol 1987; 44: 479-82.
4. GANTIER JC, PRADAT-DIEHL P, LODON P ET AL. Accidents Vasculaires cérébraux des sujets jeunes: Une étude de 133 patients agés de 9 à 45 ans. Rev Neurol 1989; 145: 437-42.
5. Antiphospholipid antibodies in Stroke Study Group: Clinical and Laboratory findings in patients with Antiphospholipid Antibodies and Cerebral Ischemia: Stroke 1990; 21: 1268-73.
6. KLEIN GM, SELAND TP. Oclussive Cerebrovascular Disease in Young Adults. Can J Neurol Sci 1984; 11: 302-4.
7. KUSHNER MJ; Prospective Study of Anticardiolipin Antibodies in Stroke. Stroke 1990; 21: 295-8.
8. FELDMANN E, LEVINE SR. Cerebrovascular Disease with Antiphospholipid Antibodies: Immune Mechanism, Significance, and Therapeutic options. Ann Neurol 1995; 37: 114-30.
9. REYNEN K. Cardiac Myxomas. N Engl J Med 1995; 1610-7.
10. BENJAMIN HG. Primary Fibromyxoma of the Heart. Arch Pathol 1939; 27: 950.
11. HEATH D. Pathology of Cardiac Tumors. Am J Cardiol 1968; 21: 315-27.
12. GOODWIN JF. Diagnosis of Left Atrial Myxoma. Lancet 1963; 1: 464-8.
13. ST JOHN SUTTON MG, MERNIER L-A, GIULIANI ER, LIE JT. Atrial Myxomas: A review of clinical experience in 40 patients. Mayo Clin Proc 1980; 55: 371-6.
14. WRISLEY D, ROSEMBERG J, GIAM BARTOLOMEI A, LEWY Y, TURIELLO C, ANTONINI T. Left Ventricular Myxoma discovered incidentally by Echocardiography. Am Heart J 1991; 121: 1554-5.
15. GREENWOOD WF. Profile of Atrial Myxoma. Am J Cardiol 1968; 21: 367-75.
16. PANIDIS ID, KOTLER MN, MINTZ GS, Ross J. Clinical and Echocardiographic Features of Right Atrial Masses. Am Heart J 1984; 107: 745-58.
17. GONZÁLEZ A, ALTIERI PI, MÁRQUEZ E, Cox RA, CASTILLO M. Massive pulmonary embolism associated with a Right Ventricular Myxoma. Am J Med 1980; 69: 795-8.
18. PETERS MN, HALL RJ, COOLEY DA, LEACHMAN RD, GARCÍA E. The Clinical Syndrome of Atrial Myxoma. JAMA 1974; 230: 695-701.
19. TRIPLETT DA. Antiphospholipid Antibodies and Thrombosis: a consequence, coincidence or cause? Arch Pathol Lab Med 1993; 117: 78-88.
20. LOCKSHIN M. Antiphospholipid Antibody Syndrome. JAMA 1992; 268: 141-5.
21. SHI LU, GORDON S, KRILIS SA ET AL. Prevalence of Lupus Anticoagulant and Anticardiolipin Antibodies in healthy Population. Aust NZ J Med 1990; 20: 231-6.
22. FIELDS RA, TOUBBEH H, SEARLES RP ET AL. The Prevalence of Anticardiolipin Antibodies in a healthy elderly Population and its association with Antinuclear Antibodies. J Rheumatol 1989; 16: 623-5.
23. ASHERSON RA, BAGULEY E, HIGHES GRN. Antiphospholipid Syndrome: Five Years Follow Up. Ann Rheum Dis 1991; 50: 805-10.
24. VIARD JP, AMOURA Z, BACH JF. Association of Anti Beta 2 Glycoprotein I Antibodies with Lupus-Type Circulation Anticoagulant and Thrombotic in Systemic Lupus Erythematosus. Am J Med 1992; 93: 181-6.
25. HASSELAAR P, DERKSSEN RHWM, BLOCKZIJL ET AL. Crossreactivity of Antibodies directed against Cardiolipin, DNA, Endothelial Cells and blood Platelets. Thromb Haemost 1990; 63: 169-73.
26. BREY RL, COULL BM. Antiphosphoslipid Antibodies origin. Specificity and Mechanism of Action. Stroke 1992; (Suppl 1): 115 -8.
27. NELSON D, GOODNIGHT SH JR. Pathologhy of Antiphospholipid Antibodies and Thrombosis and Haemostasia. Check Sample 1988, Vol 10. N TH 88-6 (TH 60). Chicago American Society of Clinical Pathologists.
28. TAIT JF, GIBSON D, FUJIKAWA J. Phospholipid Binding Properties of Human PIacental Anticoagulant 1, a member of Lipocortin Family. J Biol Chem 1989; 264: 7944-9.
29. WATSON KV, SCHORER AE. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis prone subset of patients. Am J Med 1991; 90: 48-53.
30. FUGIYASU KANDA, MD, SHIGERU UMEYAMA, MD, ATSUSHI SASAKI, MD Y COL. Interleukin 6 and Cardiac Myxoma. Am J Cardiol 1994; 74: 965-7.
31. ABBAS AK, LICHTMAN AH Y POBER JS. Cellular and Molecular Immunology W. Saunders Co. 1991; 227.